EUGENIU MIHALAS, ADRIANA BALAN, ANA PETCU (SIRGHE), LAURA GAVRILA, CARMEN SAVIN IN VIVO PILOT STUDY REGARDING THE EFFECTS OF AMOXICILLIN ON BLOOD GLUCOSE LEVELS, BODY WEIGHT AND WATER INTAKE Amoxicillin it is the most commonly prescribed antibiotic agent and the first intention in the short-term treatment of infections in children. The aim of this study was to assess the effects of amoxicillin/clavulanic acid (AMC) chronic administration on the laboratory mice’s body weight (BW), water intake and values of non-fasting blood glucose levels (n-FBG). Thus, twenty-eight C57BL/6 male mice, of similar age, randomly divided into a control and 3 treatment groups (n = 7) received subcutaneous injection, once per day, for 60 days. During the experiment the n-FBG, daily water intake, and BW changes were recorded every 10 days. The results of our study revealed that the chronic administration of AMC, at a concentration of 100 and 150 mg/kg BW/day, increased capillary n-FGB, and can be associated with a significant increase in the BW and daily water intake in mice.
Keywords: mice, amoxicillin, clavulanic acid, blood glucose, water intake, body weight